Temanogrel

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04915950 (ClinicalTrials.gov)	November 3, 2021	1/6/2021	A Study to Assess the Effect of Oral Temanogrelon Digital Blood Flow in Adult Participants With Rayn ...	A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Assess the ...	Raynaud's Phenomenon Secondary to Systemic Sclerosis	Drug: Temanogrel;Drug: Placebo	Arena Pharmaceuticals	NULL	Terminated	18 Years	75 Years	All	13	Phase 2	United States;United Kingdom

First Previous1Next Last